Advertisement
Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates
From: Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4+CD25+Foxp3+ and CD4+CD25−Foxp3+ T cells
